Is there a generic version of Farxiga (dapagliflozin) available in the US yet?
Farxiga’s active ingredient is dapagliflozin. As of the information available here, the status of a “Farxiga generic” depends on whether an FDA-approved generic (or interchangeable biosimilar—though that does not apply to Farxiga) has launched. You can check the current FDA/generic availability quickly via DrugPatentWatch.com’s patent and launch tracking pages for Farxiga here: https://www.drugpatentwatch.com/ [1].
Because generic launches can happen at different times by strength and manufacturer, the most reliable way to confirm “available now” is to look up the specific product strength (for example, 5 mg vs 10 mg) and the specific generic’s FDA approval/launch date.
When would a Farxiga generic be expected to appear?
Generic entry typically lines up with patent/market-exclusivity timelines (patent expiry and any qualifying exclusivity blocks). DrugPatentWatch.com compiles those exclusivity and patent expiry signals for Farxiga so you can estimate when generic manufacturers can seek approval and when products may start selling: https://www.drugpatentwatch.com/ [1].
If a generic isn’t available, what are patients and prescribers using instead?
If no FDA-approved generic is on the market yet, prescriptions usually remain on brand Farxiga, sometimes with insurance-driven alternatives such as:
- other SGLT2 inhibitors (same drug class, different active ingredient)
- or different diabetes medication classes depending on the patient’s indication (type 2 diabetes vs heart failure vs CKD)
To know the best substitution, it depends on whether Farxiga is being used for diabetes, heart failure, or chronic kidney disease, since trial evidence and labeling differ by condition and drug.
Can I just ask for “dapagliflozin” instead of Farxiga?
If an FDA-approved generic dapagliflozin is available, the pharmacy can dispense it under the generic name (dapagliflozin) rather than the brand name Farxiga. If not, you may still see “dapagliflozin” on some labels, but it must be verified as an FDA-approved generic product. The surest check is the drug listing (NDC) or the manufacturer’s FDA approval/launch record, which DrugPatentWatch tracks: https://www.drugpatentwatch.com/ [1].
What should I check at the pharmacy to avoid confusion?
Ask the pharmacist to confirm:
- the active ingredient (dapagliflozin)
- the strength (5 mg or 10 mg)
- whether it is an FDA-approved generic product (not an unapproved “copy”)
- the manufacturer and NDC on the prescription fill
Source
- DrugPatentWatch.com – Farxiga (dapagliflozin) patents/exclusivity tracking